200 related articles for article (PubMed ID: 15861009)
21. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
22. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J
J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093
[TBL] [Abstract][Full Text] [Related]
24. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
Cleutjens JP; Creemers EE
J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
[TBL] [Abstract][Full Text] [Related]
25. Controlling myocardial matrix remodeling: implications for heart failure.
Rao VU; Spinale FG
Cardiol Rev; 1999; 7(3):136-43. PubMed ID: 10423664
[TBL] [Abstract][Full Text] [Related]
26. [The role of changes of matrix metalloproteinase in cardiovascular diseases].
Gasanov AG; Bershova TV
Biomed Khim; 2009; 55(2):155-68. PubMed ID: 19507339
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases: regulation and dysregulation in the failing heart.
Spinale FG
Circ Res; 2002 Mar; 90(5):520-30. PubMed ID: 11909815
[TBL] [Abstract][Full Text] [Related]
28. Fibroblasts and the extracellular matrix in right ventricular disease.
Frangogiannis NG
Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
[TBL] [Abstract][Full Text] [Related]
29. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
[TBL] [Abstract][Full Text] [Related]
30. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix remodeling during the progression of volume overload-induced heart failure.
Hutchinson KR; Stewart JA; Lucchesi PA
J Mol Cell Cardiol; 2010 Mar; 48(3):564-9. PubMed ID: 19524591
[TBL] [Abstract][Full Text] [Related]
32. Changes in the myocardial interstitium and contribution to the progression of heart failure.
Eckhouse SR; Spinale FG
Heart Fail Clin; 2012 Jan; 8(1):7-20. PubMed ID: 22108723
[TBL] [Abstract][Full Text] [Related]
33. A look between the cardiomyocytes: the extracellular matrix in heart failure.
Miner EC; Miller WL
Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
[TBL] [Abstract][Full Text] [Related]
34. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.
Pauschinger M; Chandrasekharan K; Schultheiss HP
Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765
[TBL] [Abstract][Full Text] [Related]
35. Role of CyPA in cardiac hypertrophy and remodeling.
Cao M; Yuan W; Peng M; Mao Z; Zhao Q; Sun X; Yan J
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31825469
[TBL] [Abstract][Full Text] [Related]
36. Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007.
Graham HK; Horn M; Trafford AW
Acta Physiol (Oxf); 2008 Sep; 194(1):3-21. PubMed ID: 18577182
[TBL] [Abstract][Full Text] [Related]
37. Myocardial structure and matrix metalloproteinases.
Aggeli C; Pietri P; Felekos I; Rautopoulos L; Toutouzas K; Tsiamis E; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1113-31. PubMed ID: 22519443
[TBL] [Abstract][Full Text] [Related]
38. Signaling pathways that influence extracellular remodeling.
Lee RT; Lammerding J
J Card Fail; 2002 Dec; 8(6 Suppl):S339-43. PubMed ID: 12555142
[TBL] [Abstract][Full Text] [Related]
39. Matrix metallopropteinases in heart failure.
Tousoulis D; Kampoli AM; Papageorgiou N; Antoniades C; Siasos G; Latsios G; Tsiamis E; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1181-91. PubMed ID: 22519448
[TBL] [Abstract][Full Text] [Related]
40. Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stem cell (MSC) treatment of pressure overload hypertrophy.
Molina EJ; Palma J; Gupta D; Torres D; Gaughan JP; Houser S; Macha M
J Tissue Eng Regen Med; 2009 Feb; 3(2):85-91. PubMed ID: 19065545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
